158 related articles for article (PubMed ID: 6088634)
1. A human monoclonal antibody to cytomegalovirus (CMV).
Emanuel D; Gold J; Colacino J; Lopez C; Hammerling U
J Immunol; 1984 Oct; 133(4):2202-5. PubMed ID: 6088634
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus.
Ohlin M; Sundqvist VA; Gilljam G; Rudén U; Gombert FO; Wahren B; Borrebaeck CA
Clin Exp Immunol; 1991 Jun; 84(3):508-14. PubMed ID: 1710548
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulation by cytomegalovirus (CMV): helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donors.
Yachie A; Tosato G; Straus SE; Blaese RM
J Immunol; 1985 Aug; 135(2):1395-400. PubMed ID: 2409150
[TBL] [Abstract][Full Text] [Related]
4. Syngeneic monoclonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope.
Keay S; Rasmussen L; Merigan TC
J Immunol; 1988 Feb; 140(3):944-8. PubMed ID: 2448380
[TBL] [Abstract][Full Text] [Related]
5. Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells.
Steenbakkers PG; Van Wezenbeek PM; van Zanten J; The TH
Hum Antibodies Hybridomas; 1993 Oct; 4(4):166-73. PubMed ID: 7504956
[TBL] [Abstract][Full Text] [Related]
6. Human anti-cytomegalovirus (CMV) immunoglobulins secreted by EBV-transformed B-lymphocytes cell lines.
Amadei C; Michelson S; Frot JC; Fruchart MF; Nicolas H; Boué A
Dev Biol Stand; 1984; 57():283-6. PubMed ID: 6098499
[TBL] [Abstract][Full Text] [Related]
7. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
[TBL] [Abstract][Full Text] [Related]
8. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
Gustafsson B; Jondal M; Sundqvist VA
Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
[TBL] [Abstract][Full Text] [Related]
9. Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV).
Bron D; Delforge A; Lagneaux L; De Martynoff G; Bosmans E; Van der Auwera P; Snoeck R; Burny A; Stryckmans P
J Immunol Methods; 1990 Jul; 130(2):209-16. PubMed ID: 2165098
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human anti-cytomegalovirus monoclonal antibody as biologics.
Masuho Y; Matsumoto Y; Tomiyama T; Sugano T; Ono S
Dev Biol Stand; 1990; 71():127-36. PubMed ID: 2169440
[TBL] [Abstract][Full Text] [Related]
11. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.
Rosén A; Persson K; Klein G
J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902
[TBL] [Abstract][Full Text] [Related]
13. High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
[TBL] [Abstract][Full Text] [Related]
14. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
15. A human hybrid myeloma for production of human monoclonal antibodies.
Kozbor D; Tripputi P; Roder JC; Croce CM
J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
[TBL] [Abstract][Full Text] [Related]
16. Human monoclonal antibodies to cytomegalovirus recognize viral epitopes on the surface of virus-infected cells.
Larose Y; Tackaberry ES; Brodeur BR
Hum Antibodies Hybridomas; 1991 Apr; 2(2):67-73. PubMed ID: 1714785
[TBL] [Abstract][Full Text] [Related]
17. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients.
Lundgren K; Wahlgren M; Troye-Blomberg M; Berzins K; Perlmann H; Perlmann P
J Immunol; 1983 Oct; 131(4):2000-3. PubMed ID: 6311902
[TBL] [Abstract][Full Text] [Related]
19. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
[TBL] [Abstract][Full Text] [Related]
20. Generation of hybridomas producing human monoclonal antibodies against human cytomegalovirus.
Matsumoto Y; Sugano T; Miyamoto C; Masuho Y
Biochem Biophys Res Commun; 1986 May; 137(1):273-80. PubMed ID: 3013182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
